Quarterly report · Q1
2413.TEDINET S100RK8S
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥57.4bn | 2023-04-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥230.8bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥57.0bn | 2022-04-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥18.0bn | 2023-04-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥18.7bn | 2022-04-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥19.8bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥74.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥19.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥12.4bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥49.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥12.1bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥13.6bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥13.5bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥439.6bn | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥400.6bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥357.5bn | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥110.9bn | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥91.1bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥328.8bn | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥309.5bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥275.1bn | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥264.0bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥316.8bn | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥302.6bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥268.8bn | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥130.7bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥88.8bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥104.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥12.0bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥57.1bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥9.4bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥18.2bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥21.9bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥14.7bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥16.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥22.8bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥12.5bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥18.29 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥72.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥17.86 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥18.27 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥72.17 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥17.85 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 72.1% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 75.5% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 75.2% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥1.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥1.0bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥167m |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥5.6bn |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥5.6bn |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥7.0bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥6.8bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥114m |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥21.9bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥21.1bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥868m |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥8.9bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥15.7bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥15.7bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥11m |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.7bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥3m |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥831m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥57.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥56.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.0bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥18.0bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥471m |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥5.5bn |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.2bn |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥267m |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.8bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥7.2bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥7.0bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥162m |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.2bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥19.3bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥951m |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥8.8bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥14.9bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥14.9bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2m |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥4.0bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥9.9bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥304m |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.4bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥58.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥56.3bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥19.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 587
| Item | Context | Value | Unit |
|---|---|---|---|
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第24期第１四半期（自 2023年４月１日 至 2023年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)エムスリー株式会社 | |
| Company name in english cover page | FilingDateInstant | M3, Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 谷 村 格 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂一丁目11番44号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03（6229）8900（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)執行役員 大 場 啓 史 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂一丁目11番44号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03（6229）8900（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員 大 場 啓 史 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05425 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 24130 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)エムスリー株式会社 | |
| Filer name in english | FilingDateInstant | M3, Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Current period end date | FilingDateInstant | 2023-06-30 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |